New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 19, 2012
12:33 EDTACHN, HGSI, QCOM, NYT, EBAY, VZ, HUSA, MLNX, LTM, SWK, BSX, DD, BAC, GILD, GSK, YUM, MS, CY, TRVOn The Fly: Midday Wrap
Stocks on Wall Street were lower at midday, as disappointing economic data overshadowed the fact a number of prominent companies beat earnings expectations. Each of the indices has moved in a fairly wide range throughout the morning. The market opened flat after trading higher during the pre-market session. Futures weakened following disappointing jobless claims data and rumors of a downgrade of French sovereign debt. When the rumors proved to be false the averages moved back into positive territory. The poor manufacturing data from the Philadelphia Fed and the disappointing existing home sales data pushed the market to its lows of the session. The averages see-sawed near the flat line but went back into negative territory a bit after noon... ECONOMIC EVENTS: Domestically, more jobless claims applications were filed than forecast last week, as claims fell by 2,000 to 386,000 but that was above economists' calls for a drop to 370,000. Sales of previously owned homes in March unexpectedly fell 2.6% to a 4.48M annual rate from 4.6M in February. Forecasts called for an increase to 4.61M. The leading economic indicators for March showed an increase of 0.3%, versus the expected increase of 0.2%. The Philadelphia Fed manufacturing report had a reading of 8.5, versus the expected reading of 12.0. In Europe, Spain was able to sell more bonds than expected but at higher yields. Also, rumors circulated in the morning hours of an upcoming downgrade of French sovereign debt but a French senior official called the rumors unfounded and Fitch reiterated its AAA ratings and outlook on French debt... COMPANY NEWS: Bank of America (BAC) posted Q1 adjusted results that beat consensus, but shares declined 5c, or 0.56%, to $8.87. The bank said sales and trading revenue excluding accounting adjustments more than doubled from last quarter and its provision for credit losses was the smallest since the third quarter of 2007. Among other Dow components, Verizon (VZ) and Travelers (TRV) also reported earnings that exceeded expectations and both saw their shares rise following the reports, with Verizon gaining over 2% and Travellers advancing more than 4%. Du Pont (DD) was the fourth Dow name to beat on earnings, but shares fell 1.5% in midday trading... Among other companies reporting earnings, advancers included eBay (EBAY), Cypress Semi (CY), Boston Scientific (BSX), New York Times (NYT) and Morgan Stanley (MS); decliners included Stanley Black & Decker (SWK), Qualcomm (QCOM), Yum! Brands (YUM) and Life Time Fitness (LTM)... MAJOR MOVERS: Among the notable gainers were Human Genome Sciences (HGSI), up 97%, after saying it had turned down an unsolicited $13 per share buyout proposal from GlaxoSmithKline (GSK), and Mellanox (MLNX), up 43%, following upgrades from at least three firms after its Q1 earnings report and guidance. Noteworthy losers included Achillion's (ACHN), down nearly 16%, with the decline attributed by Wells Fargo to positive data for Gilead's (GILD) oral hepatitis C combination treatment, and Houston American Energy (HUSA), down 40%, after the company announced it is terminating testing on its Tamandua #1 well and confirmed and SEC investigation and three subpoenas... INDICES: Near 12:30 am ET, the Dow was down 30.32, or 0.23%, to 13,002.43; the Nasdaq was down 2.45, or 0.08%, to 3,029.00; and the S&P 500 was down 3.68, or 0.27%, to 1,381.46.
News For BAC;VZ;TRV;DD;EBAY;CY;BSX;NYT;MS;SWK;QCOM;YUM;LTM;HGSI;GSK;MLNX;ACHN;GILD;HUSA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
May 12, 2015
06:40 EDTVZVerizon downgraded to Underperform from Neutral at Macquarie
Macquarie downgraded Verizon to Underperform with a $45 price target to reflect a weaker 2016 and 2017 earnings outlook. The firm's analyst believes management has made a series of questionable strategic moves beginning with the Vodafone deal that will depress earnings. Recent advertising promotions are likely to pressure 2015 margins and ARPU and LTE capacity issues are expected in certain markets later in the year. Macquarie is surprised Verizon shares have held in around $50 with treasury yields rising and increasing Q2 promotions and does not believe this is sustainable ahead of a reset in consensus estimates.
06:02 EDTGSKGSK CEO cites 'poor choices' in rivals' M&A deals, Financial Times reports
Subscribe for More Information
05:26 EDTDDDuPont issues statement regarding Trian's statements
Subscribe for More Information
05:23 EDTBSXNevro announces filing of petitions for inter partes review by Boston Scientific
Subscribe for More Information
May 11, 2015
17:02 EDTMSMorgan Stanley to sell Global Oil Merchanting unit to Castleton Commodities
Subscribe for More Information
16:00 EDTBACOptions Update; May 11, 2015
Subscribe for More Information
15:54 EDTGSKGlaxo CEO defends strategy, warns of risks of chasing higher prices, FT says
GlaxoSmithKline (GSK) CEO Andrew Witty defends the company's shift in focus from high-priced prescription drugs to higher volume, but lower priced, products, warning that chasing ever-higher prices risks undermining the industry and may create "its own tension that leads to some kind of change,” reported Financial Times, citing an interview. Witty acknowledges the company's asset swap with Novartis (NVS) opens the door to a potential break up, but argues there are benefits to keeping pharmaceuticals, vaccines and consumer goods together and there would be “no logic” in a split at this early time after the Novartis deal, the report added. Reference Link
14:24 EDTVZFrontier announces HSR clearance for acquisition of certain Verizon assets
Subscribe for More Information
12:51 EDTMSOn The Fly: Top stock stories at midday
Subscribe for More Information
12:28 EDTDDPeltz says 'we don't even think of not winning' DuPont proxy contest
Subscribe for More Information
12:24 EDTDDPeltz says chances for last minute deal with DuPont 'dim'
Nelson Peltz says he wants to be collaborative with DuPont, adding that he is restricted in his comments about DuPont due to legal reasons as his proxy fight with the company continues. Peltz, however, said the prospects for a last minute settlement with DuPont are "very dim" and that his last talks with DuPont were weeks ago. Peltz said he and Trian are committed to maintaining R&D levels at DuPont. Nelson Peltz of Trian Fund Management is speaking on CNBC.
11:32 EDTDDDuPont indicates support from CalPERS, others for board nominees
Subscribe for More Information
09:58 EDTBACBarclays expected to pay GBP2B to settle forex rigging charges, FT says
Subscribe for More Information
09:37 EDTQCOM, BACActive equity options trading on open
Subscribe for More Information
08:18 EDTMS, BACBanks executives seek to push back on 'false, damaging' statements, WSJ reports
Subscribe for More Information
08:04 EDTYUMYum! Brands price target raised to $109 from $93 at Bernstein
Bernstein says that Yum's China comps appear to have turned the corner, while worries about the underlying weakness of its China business are contradicted by evidence. It keeps an Outperform rating on the shares.
07:26 EDTQCOMQualcomm rivals questioned by EU antitrust regulators, Reuters reports
Antitrust regulators in the EU are asking Qualcomm's (QCOM) rivals about the company's business practices, Reuters reports, citing a document. Europe has been investigating Qualcomm for the last seven months over the way it licenses its products and its power over patents. Another EU inquiry, which began in 2010, was triggered by a complained from Nvidia's (NVDA) Icera unit over rebates and incentives. Reference Link
07:07 EDTMSMorgan Stanley announces sale of Creative Circle to On Assignment
Subscribe for More Information
06:05 EDTVZSpherix issued standard-essential patent by USPTO
Spherix (SPEX) announced that the United States Patent & Trademark Office, or USPTO, is issuing the company another standard-essential patent. The company has received from the USPTO an issue notification for patent RE45521, set to issue on May 19. This patent is part of the same family of standard-essential patents currently being litigated against both Cisco (CSCO) and Verizon (VZ). The patented technology relates to the transmittal of data over a network and further enhances the company's existing portfolio.
05:58 EDTGSKUNC, GlaxoSmithKline create dedicated HIV Cure center
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use